Chinese partners are not expected to sell their stakes in mutual fund joint ventures.

Chinese partners are not expected to sell their stakes in mutual fund joint ventures.
The US asset manager argues that investors should look beyond public markets for income generating assets more insulated from Covid-19 and central bank activities.
JP Morgan AM’s product invests in global sustainable bonds, while Manulife IM’s fund focuses on Asia.
Steven Billiet joined the firm earlier this year as head of Apac distribution and was previously JP Morgan AM’s Singapore CEO.
Investors should not be concerned about the rich valuations of US tech and healthcare companies, argues JP Morgan AM’s Tai Hui.
The benchmark-agnostic product can invest in onshore and offshore China fixed income securities to generate high income, according to the fund managers.
Multi-asset funds are meant to provide protection when a particular asset class tanks, but struggle to achieve their promise when normal asset class correlations break down.
Certain travel-related companies continue to exist despite the Covid-19 pandemic and they have long-term investment appeal, says a portfolio manager at the firm.
UBS Global Asset Management is still the leading foreign fund manager in China, but JP Morgan Asset Management has closed the gap, according to Broadridge Financial’s China Power Ranking.
FSA compares two highly-rated China equity funds: the JP Morgan China Fund and the UBS China Opportunity Fund.
Part of the Mark Allen Group.